|
8. Hep B, Hib and yellow fever in phase 2
- Hep B, Hib and Yellow Fever vaccine support policies in Phase 2 should be revisited so that underlying issues such as co-financing and transition to combination vaccines are integrated.
The Board:
8.1 Requested the Secretariat to lead a process to develop recommendations for any revision of policies regarding support for Hep B and Hib in GAVI phase 2, ensuring appropriate technical and policy input, for submission to the July meeting.
8.2 Requested a regional team to evaluate the progress on yellow fever, including the yellow fever stockpile, and provide recommendations for Phase 2 by July Board.
|